Summary by Moomoo AI
FOSUN PHARMA announced that its controlling subsidiary Ningbo Fuying plans to increase its Shareholding in three Funds by a total of 0.14042 billion yuan. Specifically, Ningbo Fuying will acquire portions of shares in the Nanjing Xinjian Ruijing Fund, Dalian Xingweilai Fund, and Suzhou Xingsheng Yuanfeng Fund, for 90.92 million yuan, 25 million yuan, and 24.5 million yuan respectively from FOSUN High Technology.After the Trade is completed, FOSUN PHARMA Group's subscribed shareholding proportions in these three Funds will increase to 66.24%, 51.00%, and 64.20%, respectively, while the controlling shareholder FOSUN High Technology will no longer directly hold shares of these Funds. These three Funds mainly invest in innovative companies in the health sector, covering fields such as Biomedical and medical instruments.This transaction has been approved...Show More
